Diversity Supplement to R35 - Mechanistic Elucidation and Targeted Therapy of Organ Injury and Inflammation following Trauma
R35 的多样性补充 - 创伤后器官损伤和炎症的机制阐明和靶向治疗
基本信息
- 批准号:10627526
- 负责人:
- 金额:$ 9.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAcute Lung InjuryAddressAge-YearsAgonistAirAmazeApoptosisAppointmentAreaAttenuatedAutomobile DrivingAwardBiochemicalBiologyBlood PlateletsBlood TransfusionBlood VesselsBlood coagulationCaringCause of DeathCessation of lifeChemotaxisChemotherapy-Oncologic ProcedureClinicalClinical ResearchClinical TrialsCoagulation ProcessCollaborationsCritical IllnessData AnalysesDefectDevelopmentDevelopment PlansDiseaseDoctor of PhilosophyDrug Delivery SystemsDrug TargetingEndothelial CellsEndotheliumEventFacultyFibrinFosteringFunctional disorderFundingGenderGoalsHMGB1 ProteinHemorrhageHemostatic functionHispanicHospitalsHydroxychloroquineImmuneImmune systemImmunomodulatorsIndividualInferior vena cava structureInflammasomeInflammationInflammatoryInjuryInnate Immune ResponseInterleukin-1 betaJournalsKidneyKnowledgeLaboratoriesLeadLigationLinkLiposomesLungMalignant neoplasm of pancreasManuscriptsMediator of activation proteinMedicalMedical centerMedicineMentorsMentorshipMicrofluidicsModernizationMolecularMorbidity - disease rateMultiple Organ FailureNanotechnologyNeedlesNeoadjuvant TherapyNeutrophil ActivationNeutrophil InfiltrationNew EnglandOncologyOperative Surgical ProceduresOrganOutcomePathogenesisPathologyPatientsPatternPhasePhysiciansPlasmaPlatelet ActivationPlatelet Count measurementPositioning AttributePreventionProcessProductionProgram DevelopmentProspective cohort studyProteinsPublicationsPublishingRandomized Controlled TrialsRegulationResearchResearch AssistantResuscitationRiskRisk FactorsRoleSampling StudiesScienceScientistSecureSepsisSignaling ProteinSurvivorsSystemTLR4 geneTeacher Professional DevelopmentTechniquesTestingTherapeuticThrombocytopeniaThrombosisThrombusTimeTranexamic AcidTraumaTrauma ResearchTrauma patientUnderrepresented PopulationsUniversitiesVascular DiseasesVenousWhole BloodWorkbasecareer developmentclinical applicationclinical investigationdesigndisabilitydiversity and inclusionexosomeexperienceexperimental studyextracellularextracellular vesicleshuman diseaseimmune activationimmunothrombosisimprovedinnovationinsightintravital microscopylung injurymembermonocytemortalitymouse modelnanoparticleneutrophilnovelnovel therapeuticsorgan injuryparent grantplatelet functionpost interventionpost-traumapreventable deathprofessorprogramsreceptorreceptor for advanced glycation endproductsresearch and developmentresponsesingle-cell RNA sequencingsuccesstargeted treatmentthromboinflammationthromboticthrombotic complicationstranslational research programtranslational studytrauma induced coagulopathy
项目摘要
Project Summary/Abstract from the Parent Grant (R35 to Matthew Neal): Multiple organ dysfunction
syndrome (MODS) is a leading cause of death after severe trauma, which is a leading cause of mortality
worldwide. MODS is thought to be a consequence of a vicious cascade of excessive inflammation and
coagulation abnormalities but remains incompletely understood. The overarching goal of our research is to
understand how trauma leads to organ injury through inflammation and clotting of blood vessels, or
immunothrombosis. Our research focus is the central role of platelet function in driving immunothrombosis
after trauma. We propose to tackle the following key knowledge gaps in the field:
1) Understand the cellular mechanisms leading to micro-thrombotic organ injury in survivors after trauma
2) Unravel the immune and inflammatory consequences of modern trauma resuscitation
3) Design targeted interventions for post-traumatic organ injury and thrombosis
Project Summary/Abstract for the Diversity Research Supplement: The career development focus of this
diversity research supplement is to foster the continuous effort of inclusion of faculty from under represented
groups by increasing diversity in the Department of Surgery at the University of Pittsburgh and the University
of Pittsburgh Medical Center. Dr. Mota Alvidrez as a Hispanic junior faculty member is a perfect candidate for
this supplement as a very promising physician scientist that brings his expertise to this research team. His
inclusion as a diverse individual will also focus in developing further his expertise in platelet biology/function,
immunothrombosis and endothelial damage using state of the art microfluidic system assessment. Inclusion
of Dr. Mota Alvidrez as faculty in our department aims to foster the success of the project but also by
increasing diversity in faculty appointments particularly by the addition of highly determined and strong-driven
individuals as Dr. Mota Alvidrez. The research supplement aims to develop Dr. Mota Alvidrez independent
research program by growing the mechanisms outlined in the parent grant with his own independent research
development plan. He has an amazing mentoring team with an outlined 5-year plan that will allow ample time
for faculty development, data analysis, mentoring and grantsmanship for him to secure independent funding
to build his research program and laboratory.
The proposed research supplement for Dr. Mota Alvidrez will focus on expanding the scope of the key
challenges in the parent grant outlined above. The scientific scope will add novel hypothesis-driven
experimental studies from the exciting preliminary plan from Dr. Mota Alvidrez to promote the development of
his independent research program focusing in immunothrombosis. Dr. Mota Alvidrez research will fill
knowledge gaps in the field of immunothrombosis in trauma while advancing the needle in post-injury care.
He proposes to study deeper into the endothelial damage post trauma by evidencing platelet receptor
shedding, particularly GPIb, leading to thrombocytopenia. His work will evaluate how dysfunctional platelets
leads to platelet sequestration and microthrombi formation by evaluating the A2 domain in von Willbrand
factor as a key mediator of multimer formation in this process.
来自父母赠款的项目摘要/摘要(R35至Matthew Neal):多个器官功能障碍
综合征(mods)是严重创伤后的主要死亡原因,这是死亡率的主要原因
全世界。国防部被认为是过度炎症的恶性级联的结果
凝血异常,但仍未完全理解。我们研究的总体目标是
了解创伤如何通过炎症和血管凝结或
免疫骨栓塞。我们的研究重点是血小板功能在驱动免疫骨骼中的核心作用
创伤后。我们建议解决该领域的以下关键知识差距:
1)了解创伤后幸存者导致幸存者微栓性器官损伤的细胞机制
2)揭示现代创伤复苏的免疫和炎症后果
3)设计针对创伤后器官损伤和血栓形成的目标干预措施
项目摘要/多样性研究补充:职业发展重点
多样性研究补充是为了促进不断纳入教师的努力
小组通过增加匹兹堡大学和大学手术系的多样性。
匹兹堡医疗中心。莫塔·阿尔维德雷斯(Mota Alvidrez)博士是西班牙裔初级教师
这种补充是一位非常有前途的医师科学家,将他的专业知识带给了这个研究团队。他的
将作为一个多元化的人都将集中在进一步发展他在血小板生物学/功能方面的专业知识,
使用最先进的微流体系统评估的状态,免疫骨栓塞和内皮损伤。包容
Mota Alvidrez博士担任我们系的教师,旨在促进该项目的成功,但也是由
教师任命的多样性增加,特别是通过增加高度确定和强大的驱动
个人为Mota Alvidrez博士。研究补充旨在开发Mota Alvidrez博士独立
通过根据自己的独立研究提高父母赠款中概述的机制来研究计划
发展计划。他拥有一个出色的指导团队,其中有一个概述的5年计划,这将使时间充足
为教师开发,数据分析,指导和赠款技巧,以确保独立资金
建立他的研究计划和实验室。
拟议的Mota Alvidrez博士的研究补充将集中于扩大密钥的范围
上面概述的父母赠款中的挑战。科学范围将添加新颖的假设驱动
来自Mota Alvidrez博士的激动人心的初步计划的实验研究,以促进
他的独立研究计划着重于免疫栓塞。 Mota Alvidrez博士将填补
在伤害后护理中推进针刺的同时,在创伤中免疫栓塞领域的知识差距。
他建议通过证明血小板受体来深入研究创伤后内皮损伤
脱落,尤其是GPIB,导致血小板减少症。他的工作将评估功能失调的血小板
通过评估Von Willbrand中的A2结构域,导致血小板隔离和微骨形成
在此过程中,因子是多聚体形成的关键调解人。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew D Neal其他文献
Precision in Transfusion Medicine.
输血医学的精确性。
- DOI:
10.1001/jama.2023.16134 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
Matthew D Neal;Beverley J Hunt - 通讯作者:
Beverley J Hunt
Time to First Whole Blood Associated With Survival-First (Whole) Blood?
首次全血的时间与生存优先(全)血相关?
- DOI:
10.1001/jamasurg.2023.7186 - 发表时间:
2024 - 期刊:
- 影响因子:16.9
- 作者:
J. Sperry;Matthew D Neal - 通讯作者:
Matthew D Neal
Tranexamic acid in trauma: After 3 hours from injury, when is it safe and effective to use again?
氨甲环酸在创伤中的应用:受伤3小时后,何时再次使用安全有效?
- DOI:
10.1111/trf.17779 - 发表时间:
2024 - 期刊:
- 影响因子:2.9
- 作者:
Christopher D Barrett;Matthew D Neal;Jonathan G Schoenecker;Robert L. Medcalf;P. Myles - 通讯作者:
P. Myles
Antithrombotic Testing Using Platelet Aggregometry Vs Small Volume Stenotic Microfluidic Device
- DOI:
10.1182/blood-2022-169344 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Lara Hoteit;Emily Mihalko;Katelin Rahn;Richard Steinman;Susan M. Shea;Matthew D Neal - 通讯作者:
Matthew D Neal
Matthew D Neal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew D Neal', 18)}}的其他基金
Mechanisms of platelet exosome-mediated acute chest syndrome in sickle cell disease
血小板外泌体介导的镰状细胞病急性胸部综合征的机制
- 批准号:
10377458 - 财政年份:2019
- 资助金额:
$ 9.91万 - 项目类别:
Mechanisms of platelet exosome-mediated acute chest syndrome in sickle cell disease
血小板外泌体介导的镰状细胞病急性胸部综合征的机制
- 批准号:
9918971 - 财政年份:2019
- 资助金额:
$ 9.91万 - 项目类别:
Mechanistic Elucidation and Targeted Therapy of Platelet Dysfunction After Trauma
创伤后血小板功能障碍的机制阐明和靶向治疗
- 批准号:
9336940 - 财政年份:2016
- 资助金额:
$ 9.91万 - 项目类别:
Mechanistic Elucidation and Targeted Therapy of Organ Injury and Inflammation following Trauma
创伤后器官损伤和炎症的机制阐明和靶向治疗
- 批准号:
10409732 - 财政年份:2016
- 资助金额:
$ 9.91万 - 项目类别:
Mechanistic Elucidation and Targeted Therapy of Platelet Dysfunction After Trauma
创伤后血小板功能障碍的机制阐明和靶向治疗
- 批准号:
9484277 - 财政年份:2016
- 资助金额:
$ 9.91万 - 项目类别:
Mechanistic Elucidation and Targeted Therapy of Organ Injury and Inflammation following Trauma
创伤后器官损伤和炎症的机制阐明和靶向治疗
- 批准号:
10649442 - 财政年份:2016
- 资助金额:
$ 9.91万 - 项目类别:
相似国自然基金
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CDK4/6抑制下调衰老中性粒细胞促炎效应改善急性肺损伤的机制和干预研究
- 批准号:82302445
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于肺间充质干细胞源外泌体lncRNA表达谱差异探讨益气活血解毒法改善脓毒症急性肺损伤的机制
- 批准号:82374400
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
基于巨噬细胞炎性小体活化探究木犀草素治疗急性肺损伤的新机制
- 批准号:82374186
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
- 批准号:82360379
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Developing a Novel E3 Ligase based Anti-inflammatory for ARDS
开发基于 E3 连接酶的新型抗 ARDS 抗炎药物
- 批准号:
10366763 - 财政年份:2022
- 资助金额:
$ 9.91万 - 项目类别:
Developing a Novel E3 Ligase based Anti-inflammatory for ARDS
开发基于 E3 连接酶的新型抗 ARDS 抗炎药物
- 批准号:
10557164 - 财政年份:2022
- 资助金额:
$ 9.91万 - 项目类别: